EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine
NCT07652034
Brain Diseases, Central Nervous System Diseases
Tacoma, Washington, United States
View Trial DetailsNCT Number: NCT05675189
Clinical study participation has historically been heavily biased toward specific demographics.
This study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine.
People with migraine who are invited to take part in medical research will benefit from the analysis of the data.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Time frame: 12 months
Contact information is provided by the study sponsor or research team.
Power Life Sciences Inc.
Industry
An In Depth Study Examining Patterns in the Clinical Trial Experiences of Migraine Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07652034
Brain Diseases, Central Nervous System Diseases
Tacoma, Washington, United States
View Trial DetailsNCT06459635
Brain Diseases, Central Nervous System Diseases
Madrid, Spain
View Trial DetailsNCT04715685
Brain Diseases, Central Nervous System Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05415020
Brain Diseases, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial Details